greengene fel-2 feasibility test

54
FEL-2 Feasibility Study: GreenGene SMITH GROUP – Hayoung Lee, Soo Lee, Iyore Olaye, Sang Yoo School of Chemical and Biomolecular Engineering Cornell University Ithaca, NY 14853 May 8, 2016

Upload: soo-hyun-lee

Post on 14-Feb-2017

48 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: GreenGene Fel-2 Feasibility Test

FEL-2 Feasibility Study: GreenGene

SMITH GROUP – Hayoung Lee, Soo Lee, Iyore Olaye, Sang Yoo

School of Chemical and Biomolecular EngineeringCornell UniversityIthaca, NY 14853

May 8, 2016

Page 2: GreenGene Fel-2 Feasibility Test

Table of Contents

I. Project StatementII. Market AnalysisIII. Process UnitsIV. Plant Location and Plant LayoutV. ConstructabilityVI. Economic AnalysisVII. Recommendation for FEL-3

2SMITHGroup GreenGene May 9, 2016

Page 3: GreenGene Fel-2 Feasibility Test

Project Statement

q Client: NanoBio Pharmaceuticals• New product : GreenGene (anti-hypertensive drug)• Modeled using Penicillin G production process

q Objective • Capture 20% of the North American market after 5 years• Produce 120% of the estimated year five demand• Assumed dosage: 100mg/day

q Determine• Capital and operating costs for the facility• Ex-plant price of GreenGene proxy

3SMITHGroup GreenGene May 9, 2016

Page 4: GreenGene Fel-2 Feasibility Test

GreenGene Feasibility Study

4SMITHGroup GreenGene

Process is financially robust based on Penicillin G studyProceed to FEL-3 Stage

May 9, 2016

Location?Fairfax, Iowa

Economic Analysis?

Price per dose at 18% DCFROR: $0.008/doseBased on Penicillin G production processAverage Competitive price per dose of hypertension API: $0.03/dose

Total Project Cost: $110 MMOperating Cost: $21 MM

Environmental Concerns?No significant environmental or safety concerns

Page 5: GreenGene Fel-2 Feasibility Test

5SMITHGroup GreenGene May 9, 2016

Market Analysis

Page 6: GreenGene Fel-2 Feasibility Test

Market Analysis

6SMITHGroup GreenGene May 9, 2016

0.00

0.50

1.00

1.50

2.00

2.50

3.00

3.50

4.00

4.50

5.00

0 1 2 3 4 5 6 7 8 9 10

Amou

nt o

f Ant

i-hyp

erte

nsiv

e Dr

ug (T

g)

YearsofProduction2019

q Target Market :

North Americans with Hypertension

q 100 mg dose per day

q Economic Goals for GreenGene:

• Capture 20 % of total market

• Supply 120% of demand by year 5

Supply estimate served as a basis for equipment sizing and economic analysis throughout FEL-2 study

Annual demand

Annual supply

High Blood Pressure Facts." Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 19 Feb. 2015. Web. 09 May 2016.

Page 7: GreenGene Fel-2 Feasibility Test

7SMITHGroup GreenGene May 9, 2016

Process Units

Page 8: GreenGene Fel-2 Feasibility Test

Process Overview

8SMITHGroup GreenGene May 9, 2016

Page 9: GreenGene Fel-2 Feasibility Test

Media Preparation

9SMITHGroup GreenGene May 9, 2016

See PFD: Process Sheet 1

Objective: Mix raw materials and sterilize the media without degrading nutrients

Page 10: GreenGene Fel-2 Feasibility Test

Media Preparation

10SMITHGroup GreenGene May 9, 2016

Page 11: GreenGene Fel-2 Feasibility Test

Fermentation

11SMITHGroup GreenGene May 9, 2016

See PFD: Process Sheet 2

Objective: Purify air to meet pharmaceutical standards / Achieve desired concentration of titer through controlled reaction kinetics

Page 12: GreenGene Fel-2 Feasibility Test

Fermentation

12SMITHGroup GreenGene May 9, 2016

Page 13: GreenGene Fel-2 Feasibility Test

Reaction Basics

13SMITH GROUP GreenGene

Main Reaction :Cell + Glucose + O2 + PAA + (NH4)2SO4

à More Cells + Penicillin G + CO2 + H2O + Heat

Penicillin G

Penillic Acid

Penicilloic Acid

Degradation of Penicillin G (Side Reactions) :

May 9, 2016

Birol, Gülnur, Cenk Ündey, and Ali Çinar. "A Modular Simulation Package for Fed-batch Fermentation: Penicillin Production." Computers & Chemical Engineering 26.11 (2002): 1553-565. Web.

Page 14: GreenGene Fel-2 Feasibility Test

0

50

100

150

200

250

300

350

400

450

500

0 50 100 150 200

Con

cent

ratio

n (g

/L)

Time (hr)

14SMITHGROUP GreenGene

[Glucose]

[Cell]

[PenicillinG]

Chemical Reaction Kinetics

• Based on Bajpai & Reuss

kinetic model

• [Cell]max = [Glucose]min

• [Cell]min = [Glucose]max

• Stress fermenter 4

May 9, 2016

After 200 total hours, 50 g/L

of [Penicillin G] is achieved

Page 15: GreenGene Fel-2 Feasibility Test

15SMITHGROUP GreenGene

Chemical Reaction Kinetics-Penicillin G

• 18th Hour [Substrate] = 0 growth is constant at a

maximum

• Batch Mode = 7 hours

• Stress = 50 hours

0

10

20

30

40

50

60

0 20 40 60 80 100 120 140

Con

cent

ratio

n (g

/ L)

Time (hr)

Batch

Stress

May 9, 2016

What about the production goal?

Page 16: GreenGene Fel-2 Feasibility Test

Penicillin G Degradation Rate

• Penicillin degradation is a first order reaction

• After 50 hours of stressing, 40g/L remains

• After 90 hours of stressing, 40g/L remains due to higher degradation rate

A. Kheirolomoom et al., The combined effects of pH and temperature on penicillin G decomposition and its stability modeling Process Biochemistry.. 35: 205-211, 1999

16SMITH GROUP GreenGene

Shorter time still yields the same amount of Penicillin G

v

ç pH 6.8

!" !!! = −!"!

!"#!! = [!"#!!]!!!!.!!"#!! !

May 9, 2016

Page 17: GreenGene Fel-2 Feasibility Test

0

10

20

30

40

50

60

0 2 4 6 8 10 12 14

Peni

cillin

G (g

/L)

pH

Sensitivity Analysis on pH

• [Penicillin G]max at pH 7

• Optimal operating range: 6.5-7.5• pH 7 ± 2 yields only 80% [Penicillin G]max

• VERY SENSITIVE!!!!

17SMITH GROUP GreenGene

Optimal pH during stressing is 6.5 – 7.5Variation in pH has a significant impact

May 9, 2016

A. Kheirolomoom et al., The combined effects of pH and temperature on penicillin G decomposition and its stability modeling Process Biochemistry.. 35: 205-211, 1999

Page 18: GreenGene Fel-2 Feasibility Test

Example of Process Control

18SMITHGroup GreenGene

q Process Control Objective• Provide oxygen to keep cells alive• Maintain constant pH at 6.5

q Process Control Strategy• Monitor the concentration of air and

pH level• Implement a feed forward control loop

based on the kinetic model

May 9, 2016

Page 19: GreenGene Fel-2 Feasibility Test

Fermentation Campaign Diagram

19SMITH GROUP GreenGene

Train 1

Train 2

Train 3

Train 4

123412343434

q Number of Reactor Trains : 4• Train 1,2 : fermenter 1, 2, 3, 4 • Train 3,4 : fermenter 3, 4

May 9, 2016

Achieved optimal operation schedule with reduced cost

Page 20: GreenGene Fel-2 Feasibility Test

Extraction

20SMITHGroup GreenGene May 9, 2016

See PFD: Process Sheet 3

Objective: Obtain a product with maximum percent yield

Page 21: GreenGene Fel-2 Feasibility Test

Extraction

21SMITHGroup GreenGene May 9, 2016

Page 22: GreenGene Fel-2 Feasibility Test

Water-rich MIBK Recovery

22SMITHGroup GreenGene May 9, 2016

See PFD: Process Sheet 4

Objective: Maintain economically and environmentally optimal recovery of extraction solvent

Page 23: GreenGene Fel-2 Feasibility Test

Water-rich MIBK Recovery

23SMITHGroup GreenGene May 9, 2016

Page 24: GreenGene Fel-2 Feasibility Test

Optimization: Water-rich MIBK Recovery

24SMITHGroup GreenGene

0

200

400

600

800

1000

1200

0 10 20 30 40 50 60 70

mol

e M

IBK

tran

sfer

red

(mol

e)

Time elapsed (min)

Optimal utilities cost achieved at 82% recovery

May 9, 2016

0

20,000

40,000

60,000

80,000

100,000

120,000

0 20 40 60 80 100 120C

ost (

$)Percent Recovery (%)

"MIBK Markets and Analysis." Web. 09 May 2016.

Page 25: GreenGene Fel-2 Feasibility Test

MIBK-rich Solvent Recovery

25SMITHGroup GreenGene May 9, 2016

See PFD: Process Sheet 5

Objective: Maintain economically and environmentally optimal recovery of extraction solvent

Page 26: GreenGene Fel-2 Feasibility Test

MIBK-rich Solvent Recovery

26SMITHGroup GreenGene May 9, 2016

Page 27: GreenGene Fel-2 Feasibility Test

IPA Solvent Recovery

27SMITHGroup GreenGene May 9, 2016

See PFD: Process Sheet 6

Objective: Maintain economically and environmentally optimal recovery of extraction solvent

Page 28: GreenGene Fel-2 Feasibility Test

IPA Solvent Recovery

28SMITHGroup GreenGene May 9, 2016

Page 29: GreenGene Fel-2 Feasibility Test

Water and Biowaste Treatment

29SMITHGroup GreenGene May 9, 2016

See PFD: Utilities Sheet 1,2

Objective: Purify water to meet pharmaceutical standards / Treat any waste produced by the plant to meet the EPA regulations

Page 30: GreenGene Fel-2 Feasibility Test

Water Treatment

30SMITHGroup GreenGene May 9, 2016

Page 31: GreenGene Fel-2 Feasibility Test

Biowaste Treatment

31SMITHGroup GreenGene May 9, 2016

Page 32: GreenGene Fel-2 Feasibility Test

Environmental and Health Issues

32SMITHGroup GreenGene

q Environmental Design Considerations

q Health Issues

May 9, 2016

Boiler • Burn off-gas from fermenters and biodigestors• Prevent toxic gas release to atmosphere

Biodigestors • Treat biowaste properly

EPA regulations • Clean Air Act• Waste effluent limitation

Protection of Plant Personnel

• Personal protective equipment: eyewear, gloves, etc.• Hazard communication trainings

Accident Prevention/Emergency Response

• Toxicity detectors to indicate exposure• In case of leakage

- Have the necessary clean up materials ready- Have trained personnel to clean up the area

"US Environmental Protection Agency." US Environmental Protection Agency. Web. 09 May 2016.

Page 33: GreenGene Fel-2 Feasibility Test

Safety Issues

33SMITHGroup GreenGene

q General Considerations• Fire prevention• Fire suppression• Dust explosion prevention

q Greatest risk: Tornado• Build underground shelter• Emergency response plan

May 9, 2016

No significant safety concerns

A. Kheirolomoom et al., The combined effects of pH and temperature on penicillin G decomposition and its stability modeling Process Biochemistry.. 35: 205-211, 1999

Page 34: GreenGene Fel-2 Feasibility Test

34SMITHGroup GreenGene May 9, 2016

Plant Location& Plant Layout

Page 35: GreenGene Fel-2 Feasibility Test

35SMITHGroup GreenGene May 9, 2016

Plant Location Considerations

• Proximity to major raw materials– Corn steep liquor

• Ease of transportation for materials/ equipment/ product– Railroad, highway

• Weather conditions– Tornado

Location: Fairfax, Iowa

Page 36: GreenGene Fel-2 Feasibility Test

Plant Layout Philosophy

36SMITHGroup GreenGene

q Safetyq Sufficient roadway

• Easy and efficient access to different unitsq Strategic placement of unit operationsq Wind Direction

May 9, 2016

Page 37: GreenGene Fel-2 Feasibility Test

Plot Plan

37SMITHGroup GreenGene May 9, 2016

Page 38: GreenGene Fel-2 Feasibility Test

OSBL

38SMITHGroup GreenGene

Fire HouseWarehouseControl RoomLaboratoryMaintenance/equipment roomAdministration BuildingMain Process Building Motor Control CenterEmergency GeneratorUninterrupted Power SupplySwitch BoardFuel Gas Supply DrumInstrument Air CompressionBackup Instrument Air Compression Guard House

May 9, 2016

Page 39: GreenGene Fel-2 Feasibility Test

39SMITHGroup GREENGENE May 9, 2016

Constructability

Page 40: GreenGene Fel-2 Feasibility Test

Project Organization

40SMITHGroup GreenGene April 27, 2016

Project Manager

Construction Manager

Plumbing Civil Electrical

ProjectAccountant

Engineering Manager

Controls Manager

Utilities Manager

ProcessSectionManagers

Fermenters Managers

DownstreamManager

SolventRecoveryManager

CommissioningManager SafetyManager

QualityInspectors

Page 41: GreenGene Fel-2 Feasibility Test

Constructability

41SMITHGroup GreenGene

Total time from planning to startup: 34 months

May 9, 2016

Page 42: GreenGene Fel-2 Feasibility Test

Labor Requirements

42SMITHGroup GreenGene

5 8 1225

40

98

165180

155

55

Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10

# of

Lar

bore

rs

Quarter of Project TImeline

May 9, 2016

Maximum number of laborers = 200Will not impact the surrounding city; labor need can be fulfilled

Page 43: GreenGene Fel-2 Feasibility Test

Startup and Shut Down Procedure

43SMITHGroup GreenGene April 27, 2016

Startup1. Activate electrical system 2. Activate fire and water systems 3. Activate natural gas/

instrument 4. Fill Cooling-water system and

circulate 5. Activate air and steam systems6. Turn on boiler7. Start air compressors8. Start feed to the biodigestor9. Sterilize media using steam10. Start up one fermenter train at

a time

Shut Down1. Remove hazardous process

materials2. Reroute streams to

designated area3. Turn heat and coolant off4. De-pressure the systems 5. Isolate the systems from other

processes 6. If shut down prolongs, protect

the equipment from deteriorating

No significant deviation from the standard procedure

Page 44: GreenGene Fel-2 Feasibility Test

44SMITHGroup GREENGENE May 9, 2016

Economic Analysis

Page 45: GreenGene Fel-2 Feasibility Test

ICARUS Summary Costs

45SMITHGroup GreenGene

Item Cost (MM$)

Equipment 9.0

Equipment Setting 0.34

Piping 5.4

Civil(Building & Construction)

16

Steel 0.54

Instrumentation(Model Base Controls)

7.0

Electrical 3.8

Insulation 0.44

Paint 0.45

Other 38

G and A Overheads 3.0

Owner’s Costs 6.6

Total Project Cost: $110 MM with 25 % contingency

May 9, 2016

Page 46: GreenGene Fel-2 Feasibility Test

Economic Analysis Breakdown

Item Cost ($MM)

Annual Amount of Product Sold 10,500 (MM of Doses)

Total Sales Revenue(at .008 cent/dose) 84

Raw Material Cost 4.0

Variable Costs 4.0

Fixed Costs 6.5

Gross Margin 74

46SMITHGroup GreenGene

Operating ramp-up:Initial Start Up: 50 % Capacity Ramp up linearly to 100 % in year 5

Determining product price:DCFROR: 18% (NPV: 0) in year 10 at 100% capacity

May 9, 2016

Page 47: GreenGene Fel-2 Feasibility Test

Economic Analysis Results

47SMITHGroup GreenGene

-120

-80

-40

0

40

80

120

-4 -2 0 2 4 6 8 10

Cas

h Fl

ow (M

M $

)

Year of Production

Pay Back Period: 3.7 Years

Cash Flow

Discounted Cash Flow

May 9, 2016

Assumptions:Depreciation = 10%Tax Rate = 38%

DCFROR = 18%Cost/dose = $0.008/dose

Page 48: GreenGene Fel-2 Feasibility Test

Sensitivity Analysis - Controllable

48SMITHGroup GreenGene

0 0.002 0.004 0.006 0.008 0.01 0.012 0.014 0.016

Years until Full Capacity

Total Invested Capital

No. of Batches

Labor Cost

Cost per Dose ($)

Attention should be given to the number of failed batches to ensure product price consistency

2 years7 years

± 30%

- 5%

± 30%

May 9, 2016

Varia

ble

Fact

ors

Page 49: GreenGene Fel-2 Feasibility Test

Sensitivity Analysis - Uncontrollable

49SMITHGroup GreenGene

0.0064 0.0069 0.0074 0.0079 0.0084 0.0089 0.0094

± 30%

± 10%

Attention should be given to the amount sold to ensureproduct price consistency.

Cost per Dose ($)

Amount Sold

Fixed Cost

Raw Material Cost

± 30%

May 9, 2016

Varia

ble

Fact

ors

Page 50: GreenGene Fel-2 Feasibility Test

Economic Analysis

50SMITHGroup GreenGene May 9, 2016

Total Project Cost: $110 MM• Working Capital: $21.0 MMCost Summary

Price/dose at 18% DCFROR: $0.008• Based on Penicillin G production

processPricing Strategy

No significant deviationInsensitive overall, thus financially robust

Sensitivity Analysis

Page 51: GreenGene Fel-2 Feasibility Test

Recommendations for FEL-3

51SMITHGroup GreenGene May 9, 2016

Page 52: GreenGene Fel-2 Feasibility Test

Recommendation for FEL-3

52SMITHGroup GreenGene

• Kinetic modeling based on GreenGene• Revisit optimization and control strategy for solvent

recovery systems• Products and in-process quality control sampling

May 9, 2016

Revalidate and modify the process based on GreenGene

Page 53: GreenGene Fel-2 Feasibility Test

Thank you

53SMITHGroup GreenGene May 9, 2016

Page 54: GreenGene Fel-2 Feasibility Test

Questions?

54SMITHGroup GreenGene May 9, 2016